Brendan, a Pennsylvanian by birth, completed his BS at Allegheny College and his Ph.D. at Stanford University in the field of organic synthesis. He has been employed by a major pharmaceutical company since graduation in 2009 and is an avid investor as well. His writings focus on a variety of topics ranging from stocks, bonds and options to analysis of recent news events relevant to financial markets.
